CIDRAP newsletters options
In other developments, antiviral susceptibility testing shows that H5N1 is susceptible to neuraminidase inhibitor antiviral drugs.
In 2021 and 2022, the virus appeared to peak early in several states and to cause more severe illness.
Black women hospitalized with BSIs caused by carbapenem-resistant Enterobacterales had more than double the risk of 30-day mortality as White women and Black men.
Pfizer's novel combination antibiotic Emblaveo (aztreonam-avibactam) will be an option for infections that have limited treatment options.
Objective definitions of medical stability guide decisions on safe hospital release, the authors say.
Last month, unusual psittacosis case rises were reported from five European countries.
A prompt in the electronic health record was tied to significant reductions in extended-spectrum antibiotics for pneumonia and urinary tract infections.
Many of the problems in the mpox response were due to a deflated and exhausted public health workforce across the country.
The return on investment of up to $4,637 per vaccination course translates to billions of dollars in net monetary benefits to society, the authors say.
Wastewater COVID detections declined to the minimal level and are highest in the Midwest.
Despite the risk of severe infection from COVID-19, the study authors found that only 40.5% of residents were up to date with COVID vaccination.
The Virginia Department of Wildlife Resources confirmed the fatal prion disease in a buck harvested by a hunter in November 2023.
Most infections occurred at lower latitudes from January to July (not including April) but were seen mainly at higher latitudes from August to December.
With the H5N1 avian flu virus now reported in 5 Michigan dairy herds, officials remind residents to avoid drinking unpasteurized milk.
The group steered away from defined cutoff points such as "droplets" and "aerosols" that scientists have used to distinguish larger particles from smaller particles.
Researchers estimate that 85 pathogens accounted for 704 million disability-adjusted life years globally in 2019.
For critical illness VE was 38% if the last dose was received any time within the previous year.
The findings suggest that older patients with severe COVID-19 may respond more favorably to immunomodulatory therapies aimed at certain inflammatory cytokines, the authors say.
So far 12 illnesses in 7 states are confirmed in the outbreak.
Diagnostics and health technology company Scout say its test can detect gonorrhea infections in 30 minutes, at less than half the cost of other options.
